Post A Reply
my profile
login
|
register
|
search
|
faq
|
forum home
»
Allstocks.com's Bulletin Board
»
Micro Penny Stocks, Penny Stocks $0.10 & Under
»
XKEM
» Post A Reply
Post A Reply
Login Name:
Password:
Message Icon:
Message:
HTML is not enabled.
UBB Code™ is enabled.
[QUOTE]Originally posted by rocktrader: [QB] Nice read about XKEM....when is this summit and what is the significance? I may get some position in this...it looks very promising... *** XKEM on its way BACK to fair market value *** Conversion almost done and if not will have little effect in this reversal. GET IN BEFORE THE MASSES DO.... ONE trading day left until Nigerian SUMMIT XKEM is the most watched penny out there.. The money flow speaks for itself... 14.6 Million last Friday, 7.8 Million last Monday, 6.0 Million last Tuesday, 9.6 Million last Wednesday 7.6 Million last Thursday 4.3 Million last Friday 7.7 Million on Monday (on a half day trading) 21.7 Million on Wednesday (a new record) 18.2 Million on Thursday 6.0 Million on Friday 7.1 Million this Monday 9.2 Million this Tuesday 6.2 Million this Wednesday 6.6 Million Today ===== 132.6 Million in last 13 trading days. No PENNY under a $1. trades like this GEM. Look for yourself. [URL=http://bigcharts.marketwatch.com/markets/screener.asp?exchange=118&screen=8&x=21&y=27]http://bigcharts.marketwatch.com/markets/screener.asp?exchange=118&screen=8&x=21 &y=27[/URL] *** FOLLOW THE SMART MONEY *** A stock with this enormous potential cannot be held down by MM manipulation for long and the MM's stretched it to the limit.. so it will rebound hard. *** Watch for major bounce within the next 2 trading days *** Those who panic sold the last few days, the time to get back in is tomorrow. Hope for sickle cell patients http://www.tribune.com.ng/14072006/edit.html Obasanjo to commission sickle cell drug factory today http://www.businessdayonline.com/?c=44&a=7409 The masses will become more aware of this GEM on every passing day. Xechem Receives Approval For Sale Of NICOSAN(TM) From Nigerian Regulatory Authorities -- NAFDAC The company faces no restrictions on its ability to market and sell the drug in Nigeria. http://biz.yahoo.com/bw/060705/20060705005761.html?.v=1 Hold on tight to those precious XKEM shares. Expected short term PR list. ---------------------------- PR#1 - Non-dilutive 8.2 Million Dollar loan. PR#2 - Start of production. PR#3 - Exporting to other countries Bank wants to double their initial investment (for good reason) http://www.cometnewsonline.com/capital.html With latest 8K, OS is now confirmed at 1.2B. Lets make it 2 Billion since we do not know how much conversion was done, so we will take the worst case even though it will be less. In Nigeria alone, there are 4,000,000 SCD patients. NICOSAN™ $20/month (conservative) = $240/year $240 x 4,000,000 SCD patients = $960,000,000 US dollars. Let’s assume at least 50% margins. Earnings = $480,000,000 Price-Earnings Ratio - P/E Ratio http://www.investopedia.com/terms/p/price-earningsratio.asp The P/E is sometimes referred to as the "multiple", because it shows how much investors are willing to pay per dollar of earnings. If a company were currently trading at a multiple (P/E) of 20, the interpretation is that an investor is willing to pay $20 for $1 of current earnings. Now lets take BRISTOL MYERS SQIBB (BMY) BMY has a P/E of approximately 15 and a market CAP of $$$ 49 Billion $$$. Oh yes, didn't XKEM just win a 4 Million Dollar law suit against the BMY giant. See for yourself. (Impressive indeed) [URL=http://www.marketwire.com/mw/release_printer_friendly?release_id=104501&category=]http://www.marketwire.com/mw/release_printer_friendly?release_id=104501&category =[/URL] $480,000,000 * 15 = approx $7,000,000,000 Divide by the maximum number of outstanding shares (approx 2 Billion) worst case ... $14,000,000,000 / 2,000,000,000 = $7.00 Now let's say they only get to sell to 10% of the people at first. Why only 10 percent you ask? - Difficulty to ramp up production at first.. However the demand is there, just need to get production to the level of the demand. (Imagine opening a business where your sales are already pre-determined and waiting for you to simply act on them) Let’s not forget how this will improve the lives of millions of sufferers and the publicity that it will create. This is a WIN WIN for all involved. 10% of $7.00= $.70 stock.. Now add the rest of Africa (another 5 million cases) (as production increases) easy double.. $1.40 Now export the drug to the rest of the world.... Over time, allow the production to ramp up & increase sales from 10% to 50% Still want to give away your shares under 1.00 ? (and before the imminent PR’s above) This is minimum a 400 Million dollar company and we have a 40 Million dollar market CAP. (that is a 10 bagger minimum) Wake UP people and start buying... Some past PR's.. ================ Xechem Receives Orphan Drug Designation From The FDA For Its Anti-Sickling Drug 5-HMF 6 Jun 2006 (BusinessWire) Xechem's Subsidiary -- Xechem Pharmaceuticals Nigeria -- Receives N150 Million Naira... 1 Jun 2006 (BusinessWire) Xechem Files Orphan Drug Application with the FDA For The Anti-Sickling Compound... 14 Mar 2006 (BusinessWire) Xechem Closes On $4.2 Million Lawsuit Settlement With Bristol-Meyers Squibb 25 Jan 2006 (BusinessWire) Xechem Completes Repurchase of $3 Million Convertible Loan From Alembic; Alembic... 12 Jan 2006 (BusinessWire) Xechem Receives $560,000 From Sale Of New Jersey State Net Operating Losses 29 Dec 2005 (BusinessWire) Xechem Settles Antitrust Lawsuit Against Bristol-Meyers Squibb for $4.2 Million 20 Dec 2005 (BusinessWire) Xechem Expands its Arsenal for Treating Sickle Cell Disease; Licenses New Anti-Sickling... 9 Dec 2005 (BusinessWire) [/QB][/QUOTE]
Instant Graemlins
Instant UBB Code™
What is UBB Code™?
Options
Disable Graemlins in this post.
*** Click here to review this topic. ***
Contact Us
|
Allstocks.com Message Board Home
© 1997 - 2021 Allstocks.com. All rights reserved.
Powered by
Infopop Corporation
UBB.classic™ 6.7.2